BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2013
View Archived Issues
Nintedanib shows no activity against recurrent high-grade gliomas
Read More
Phase II trial planned after phase I study completed with selumetinib in children with gliomas
Read More
Bispecific hexavalent antibody shows promise for treating lupus
Read More
ImmunoCellular Therapeutics reports phase II data for ICT-107
Read More
Integral Molecular generates MAbs against the P2X3 ion channel
Read More
KaloBios Pharmaceuticals presents phase I results for KB-004
Read More
AGI-14100 significantly reduces tumor burden in IDH1-mutant mouse model
Read More
Swiss group discloses new MPC modulators
Read More
Convergence Pharmaceuticals prepares novel sodium channel blockers for pain
Read More
New potassium channel modulators patented by Autifony Therapeutics
Read More
Piramal Enterprises synthesizes new pyrimidine compounds
Read More
Korean researchers present new antibodies that bind to RANKL for bone disorders
Read More
Mallinckrodt completes clinical trials of MNK-155
Read More
Novel Trk-A inhibitors designed by Merck & Co.
Read More
SPX-106T lowers cholesterol and triglyceride levels and prevents weight gain in vivo
Read More
Canadian approval for Lemtrada
Read More
FDA advisory committee votes in favor of Oralair for grass pollen allergy
Read More
Stem cell candidate receives orphan drug designation in Japan
Read More
FDA advisory committee recommends approval of dapagliflozin
Read More
Celator's phase III study of CPX-351 for AML cleared to continue by DSMB
Read More
CDRD Ventures launches spin-off company Kairos Therapeutics
Read More
Dementia Consortium launched in the UK to advance drug development
Read More
FDA approves Complera for patients with HIV switching from a stable regimen
Read More
Endocyte begins phase I study of EC-1456 in advanced solid tumors
Read More